ProShare Advisors Portfolio holdings
AUM
$50.1B
1-Year Return
23.39%
This Quarter Return
-2.53%
1 Year Return
+23.39%
3 Year Return
+95.6%
5 Year Return
+167.57%
10 Year Return
+417.51%
AUM
$44.3B
AUM Growth
+$548M
(+1.3%)
Cap. Flow
+$2.39B
Cap. Flow
% of AUM
5.4%
Top 10 Holdings %
Top 10 Hldgs %
27.39%
Holding
2,291
New
20
Increased
497
Reduced
1,558
Closed
210
Top Buys
| 1 |
Apple
AAPL
|
$215M |
| 2 |
Eversource Energy
ES
|
$187M |
| 3 |
Microsoft
MSFT
|
$184M |
| 4 |
Erie Indemnity
ERIE
|
$182M |
| 5 |
Factset
FDS
|
$165M |
Top Sells
| 1 |
Cardinal Health
CAH
|
$48.8M |
| 2 |
Emerson Electric
EMR
|
$47.1M |
| 3 |
Walmart
WMT
|
$41.1M |
| 4 |
Williams-Sonoma
WSM
|
$36.2M |
| 5 |
IBM
IBM
|
$35.7M |
Sector Composition
| 1 | Technology | 30.94% |
| 2 | Consumer Staples | 10.31% |
| 3 | Consumer Discretionary | 10.1% |
| 4 | Financials | 9.92% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TE
2001
T1 Energy Inc.
TE
$309M
| $30.6K | ﹤0.01% |
24,270
-7,303
| -23% | -$9.2K |
|
2002
AbCellera Biologics
ABCL
$1.25B
| $30K | ﹤0.01% |
13,443
-547
| -4% | -$1.22K |
|
2003
Montauk Renewables
MNTK
$293M
| $29.9K | ﹤0.01% |
14,288
-4,300
| -23% | -$8.99K |
|
2004
Leslie's
LESL
$63.3M
| $29.5K | ﹤0.01% |
40,159
-14,109
| -26% | -$10.4K |
|
2005
Telos
TLS
$460M
| $28.4K | ﹤0.01% |
11,924
-3,588
| -23% | -$8.54K |
|
2006
scPharmaceuticals
SCPH
$300M
| $28.4K | ﹤0.01% |
10,784
-2,681
| -20% | -$7.05K |
|
2007
CureVac
CVAC
$1.2B
| $28K | ﹤0.01% |
10,120
-507
| -5% | -$1.4K |
|
2008
Entravision Communication
EVC
$227M
| $28K | ﹤0.01% |
13,311
-4,007
| -23% | -$8.42K |
|
2009
TrueCar
TRUE
$195M
| $27.8K | ﹤0.01% |
17,609
-6,514
| -27% | -$10.3K |
|
|
GPMT
2010
Granite Point Mortgage Trust
GPMT
$141M
| $27.7K | ﹤0.01% |
10,668
-3,511
| -25% | -$9.13K |
|
2011
Alector
ALEC
$279M
| $27.3K | ﹤0.01% |
22,221
-5,146
| -19% | -$6.33K |
|
2012
Nkarta
NKTX
$151M
| $26.9K | ﹤0.01% |
14,637
-3,607
| -20% | -$6.64K |
|
2013
Outdoor Holding Company Common Stock
POWW
$169M
| $26.8K | ﹤0.01% |
19,419
-5,843
| -23% | -$8.06K |
|
2014
Nektar Therapeutics
NKTR
$843M
| $26.3K | ﹤0.01% |
2,576
-776
| -23% | -$7.92K |
|
|
ONL
2015
Orion Office REIT
ONL
$171M
| $26K | ﹤0.01% |
12,155
-3,658
| -23% | -$7.83K |
|
2016
C4 Therapeutics
CCCC
$193M
| $26K | ﹤0.01% |
16,223
-4,060
| -20% | -$6.5K |
|
2017
Holley
HLLY
$451M
| $25.9K | ﹤0.01% |
10,080
-3,032
| -23% | -$7.79K |
|
2018
Lyell Immunopharma
LYEL
$250M
| $25.8K | ﹤0.01% |
2,398
-526
| -18% | -$5.66K |
|
2019
Larimar Therapeutics
LRMR
$336M
| $25.8K | ﹤0.01% |
11,985
-2,885
| -19% | -$6.2K |
|
2020
Neumora Therapeutics
NMRA
$269M
| $25.7K | ﹤0.01% |
25,738
-5,604
| -18% | -$5.6K |
|
2021
Editas Medicine
EDIT
$251M
| $25.1K | ﹤0.01% |
21,666
-5,586
| -20% | -$6.48K |
|
2022
Perspective Therapeutics
CATX
$255M
| $24.9K | ﹤0.01% |
11,702
-3,523
| -23% | -$7.5K |
|
2023
ADC Therapeutics
ADCT
$396M
| $24.8K | ﹤0.01% |
17,605
-5,296
| -23% | -$7.47K |
|
2024
Rackspace Technology
RXT
$347M
| $24.7K | ﹤0.01% |
14,629
-4,401
| -23% | -$7.44K |
|
2025
PLAYSTUDIOS Inc
MYPS
$121M
| $24.2K | ﹤0.01% |
19,058
-5,735
| -23% | -$7.28K |
|